These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35663436)

  • 41. [Food patterns in Russian patients with gastroesophageal reflux disease: the results of pilot comparative study].
    Kropochev VS; Morozov SV; Lantseva MA; Sasunova AN; Pilipenko VI; Isakov VA
    Ter Arkh; 2020 Sep; 92(8):66-72. PubMed ID: 33346464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Value of adjunctive evidence from MII-pH monitoring and high-resolution manometry in inconclusive GERD patients with AET 4-6.
    Jiang Y; Jiang L; Ye B; Lin L
    Therap Adv Gastroenterol; 2021; 14():17562848211013484. PubMed ID: 34104208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The study and comparative analysis of GerdQ and GSRS Questionnaires on gastroesophageal reflux disease diagnostics.
    Zaika S; Paliy I; Chernobrovyi V; Ksenchyn OO
    Prz Gastroenterol; 2020; 15(4):323-329. PubMed ID: 33777272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication.
    Frazzoni M; Piccoli M; Conigliaro R; Manta R; Frazzoni L; Melotti G
    Surg Endosc; 2013 Aug; 27(8):2940-6. PubMed ID: 23436097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain.
    Dekel R; Martinez-Hawthorne SD; Guillen RJ; Fass R
    J Clin Gastroenterol; 2004 Jan; 38(1):24-9. PubMed ID: 14679323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease.
    Visaggi P; Del Corso G; Gyawali CP; Ghisa M; Baiano Svizzero F; Stefani Donati D; Venturini A; Savarino V; Penagini R; Zeki S; Bellini M; Savarino EV; de Bortoli N
    Am J Gastroenterol; 2023 May; 118(5):794-801. PubMed ID: 36633477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of esophageal manometry and 24-h pH testing in patients with refractory reflux symptoms.
    Jain M; Agrawal V
    Indian J Gastroenterol; 2020 Apr; 39(2):165-170. PubMed ID: 32388711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of gastroesophageal reflux disease in Uygur and Han Chinese adults in Urumqi.
    Niu CY; Zhou YL; Yan R; Mu NL; Gao BH; Wu FX; Luo JY
    World J Gastroenterol; 2012 Dec; 18(48):7333-40. PubMed ID: 23326142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of antisecretory therapy and study duration on ambulatory esophageal pH monitoring.
    Kushnir VM; Sayuk GS; Gyawali CP
    Dig Dis Sci; 2011 May; 56(5):1412-9. PubMed ID: 21046245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction?].
    Labenz J; Labenz G; Stephan D; Willeke F;
    MMW Fortschr Med; 2016 May; 158 Suppl 4():7-11. PubMed ID: 27221555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Higher Esophageal Symptom Burden in Obese Subjects Results From Increased Esophageal Acid Exposure and Not From Dysmotility.
    Rogers BD; Patel A; Wang D; Sayuk GS; Gyawali CP
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1719-1726. PubMed ID: 31442604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value?
    Tolone S; De Bortoli N; Marabotto E; de Cassan C; Bodini G; Roman S; Furnari M; Savarino V; Docimo L; Savarino E
    Neurogastroenterol Motil; 2015 Oct; 27(10):1423-31. PubMed ID: 26227513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon.
    Savarino EV; Tolone S; Bartolo O; de Cassan C; Caccaro R; Galeazzi F; Nicoletti L; Salvador R; Martinato M; Costantini M; Savarino V
    Aliment Pharmacol Ther; 2016 Sep; 44(5):522-30. PubMed ID: 27373195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD.
    Tolone S; de Cassan C; de Bortoli N; Roman S; Galeazzi F; Salvador R; Marabotto E; Furnari M; Zentilin P; Marchi S; Bardini R; Sturniolo GC; Savarino V; Savarino E
    Neurogastroenterol Motil; 2015 Aug; 27(8):1175-82. PubMed ID: 26010058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparison of clinical features between gastroesophageal reflux diseases with atypical and typical symptoms].
    Men RT; Yi ZH; Yang ZB; Xiao Q; Yang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):484-8. PubMed ID: 24941824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
    Patel A; Sayuk GS; Kushnir VM; Chan WW; Gyawali CP
    Neurogastroenterol Motil; 2016 Apr; 28(4):513-21. PubMed ID: 26686239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symptoms, endoscopic findings and reflux monitoring results in candidates for bariatric surgery.
    Heimgartner B; Herzig M; Borbély Y; Kröll D; Nett P; Tutuian R
    Dig Liver Dis; 2017 Jul; 49(7):750-756. PubMed ID: 28302442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
    Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
    Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease.
    Morozov S; Isakov V; Konovalova M
    World J Gastroenterol; 2018 Jun; 24(21):2291-2299. PubMed ID: 29881238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.